Irish tech firm Oneview signs up New York healthcare provider
Published 24/05/2016 | 02:30
A software provider which this year became the first Irish company listed on Australia's stock market has secured a multi-million dollar US hospital contract.
Dublin-based and Sydney- listed Oneview Healthcare signed the multi-year contract with NYU Langone Medical Center, a healthcare provider linked to New York University.
The contract will see NYU Langone Medical Center use Oneview's medical software, initially at its 374-bed Helen L and Martin S Kimmel Pavilion site, and then rolled out across the NYU system. NYU operates five hospitals, clinics and medical centres throughout New York City's five boroughs, and in neighbouring Long Island, New Jersey, and Westchester, Putnam, and Dutchess counties.
Oneview's software allows doctors and nurses to work more efficiently by accessing real-time information about the patient.
Oneview said its platform helps improve productivity, reduce waste and reduce costs for hospitals, and at the same time helps deliver better clinical outcomes for patients while dramatically improving the experience for patients while they are in hospital. "Patients at NYU facilities will benefit from the Oneview software, which includes apps that can be installed on personal tablets and smartphones, which will allow patients to learn more about their condition, track their treatment and progress," the company's president and founder, Mark McCloskey, said.
"In addition, patients can exchange messages with doctors and nursing staff, access a wide range of information and entertainment via the internet, live free-to-air and cable TV and stay connected to family and friends via live video streaming services such as Skype," he said.
Mr McCloskey is a finalist in this year's EY Entrepreneur of the Year programme.
In March, Oneview Healthcare became the first Irish company to raise equity through a listing on the Australian Securities Exchange (ASE), securing A$62.4m (€42m) through a flotation of a third of the business in a deal to fund "aggressive growth of its digital platform that is revolutionising patient care in Australia, the USA and the Middle East".
The location of the listing reflects the role of Australian shareholders who had backed the software business with venture funding.